Immunological study reveals persistent T cell activity in older survivors of SARS-CoV-2 pneumonia, suggesting mechanisms for post-acute lung sequelae.
T cells contributing to persistent tissue conditions after COVID-19. Our results have revealed pathophysiological and immune traits that may support the development of lung sequelae after SARS-CoV-2 pneumonia in older individuals, with implications for the treatment of chronic COVID-19 symptoms.
No takes yet. Share an insight, caveat, or question.
Cheon et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: